GRCE
Grace Therapeutics, Inc.
$2.37
+0.13 (+5.80%)
At close · Jul 2
Market Cap
$38.57M
Shares
16,274,026
Earnings calls and other investor events (conferences, investor days) grouped as single events — the transcript and audio, plus, for earnings calls, the 8-K earnings release and the quarter's 10-Q or 10-K. Each badge shows which artefacts have landed.
| Period | Call date | Event | Artefacts | Open |
|---|---|---|---|---|
| FY2026 Q4 | 2026-06-18 | Grace Therapeutics, Inc. Q4 FY2026 Earnings Call |
Audio
Transcript
Slides
8-K10-K
|
|
| FY2026 Q3 | 2026-02-12 | Grace Therapeutics, Inc. Q3 FY2026 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2026 Q2 | 2025-11-13 | Grace Therapeutics, Inc. Q2 FY2026 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2026 Q1 | 2025-08-12 | Grace Therapeutics, Inc. Q1 FY2026 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2025 Q4 | 2025-06-23 | Grace Therapeutics, Inc. Q4 FY2025 Earnings Call |
Audio
Transcript
Slides
8-K10-K
|
|
| FY2025 Q3 | 2025-02-13 | Grace Therapeutics, Inc. Q3 FY2025 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2025 Q2 | 2024-11-13 | Grace Therapeutics, Inc. Q2 FY2025 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2025 Q1 | 2024-08-09 | Grace Therapeutics, Inc. Q1 FY2025 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2024 Q4 | 2024-06-21 | Grace Therapeutics, Inc. Q4 FY2024 Earnings Call |
Audio
Transcript
Slides
8-K10-K
|
|
| FY2024 Q3 | 2024-02-12 | Grace Therapeutics, Inc. Q3 FY2024 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2024 Q2 | 2023-11-13 | Grace Therapeutics, Inc. Q2 FY2024 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2024 Q1 | 2023-08-11 | Grace Therapeutics, Inc. Q1 FY2024 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2023 Q4 | 2023-06-23 | Grace Therapeutics, Inc. Q4 FY2023 Earnings Call |
Audio
Transcript
Slides
8-K10-K
|
|
| FY2023 Q3 | 2023-02-14 | Grace Therapeutics, Inc. Q3 FY2023 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2023 Q2 | 2022-11-14 | Grace Therapeutics, Inc. Q2 FY2023 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2023 Q1 | 2022-08-11 | Grace Therapeutics, Inc. Q1 FY2023 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2022 Q4 | 2022-06-21 | Grace Therapeutics, Inc. Q4 FY2022 Earnings Call |
Audio
Transcript
Slides
8-K10-K
|
|
| FY2022 Q3 | 2022-02-14 | Grace Therapeutics, Inc. Q3 FY2022 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2022 Q2 | 2021-11-10 | Grace Therapeutics, Inc. Q2 FY2022 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2022 Q1 | 2021-08-12 | Grace Therapeutics, Inc. Q1 FY2022 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2021 Q4 | 2021-06-22 | Grace Therapeutics, Inc. Q4 FY2021 Earnings Call |
Audio
Transcript
Slides
8-K10-K
|
|
| FY2021 Q3 | 2021-02-09 | Grace Therapeutics, Inc. Q3 FY2021 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2021 Q2 | 2020-11-16 | Grace Therapeutics, Inc. Q2 FY2021 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2021 Q1 | 2020-08-13 | Grace Therapeutics, Inc. Q1 FY2021 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2020 Q4 | 2020-06-29 | Grace Therapeutics, Inc. Q4 FY2020 Earnings Call |
Audio
Transcript
Slides
8-K10-K
|
Showing 1–25 of 25 earnings calls
Key facts
CIK
1444192
CUSIP
00439U104